A randomized, double-blind, parallel-design, placebo-controlled study across multiple research centers aims to evaluate the efficacy and safety of UTHEVER® NMN supplements.

Conclusion:

In this study, the elevated NAD+ levels on days 30 and 60, along with the corresponding NADH/NADH ratio, demonstrate that UTHEVER's potential to increase cellular NAD+ levels is associated with higher energy levels and anti-aging effects. Increased insulin sensitivity was also associated with anti-aging. Furthermore, the safety and efficacy of oral administration of NMN 300 mg in healthy individuals have been confirmed, and this oral administration of NMN 300 mg did not cause any specific adverse effects in healthy volunteers.

Link: The rise in the levels of NAD+ /NADH at day 30 and day 60 illustrated the potential of Uthever to raise the levels of NAD+ in the cells, which is linked to higher energy levels and an anti-aging effect. Increased sensitivity to insulin has also been linked to anti-aging (Published in Frontiers in Aging, May 2022)